Difficult Intravenous Access Clinical Trial
Official title:
Prospective Observational Study of Difficult Intravenous Access in the Operating Room
NCT number | NCT03591016 |
Other study ID # | IRB18-00495 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 2, 2018 |
Est. completion date | December 8, 2020 |
Verified date | February 2021 |
Source | Nationwide Children's Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This is an observational study only, where number of attempts to establish peripheral IV catheter placement will be recorded during procedures in all anesthetizing location on the main campus of Nationwide Children's Hospital.
Status | Completed |
Enrollment | 1000 |
Est. completion date | December 8, 2020 |
Est. primary completion date | December 8, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 18 Years |
Eligibility | Inclusion Criteria: - Patients 0-18 years of age - Having surgery at Nationwide Children's Hospital Exclusion Criteria: - Pre-existing IV upon arrival to the operating room |
Country | Name | City | State |
---|---|---|---|
United States | Nationwide Children's Hospital | Columbus | Ohio |
Lead Sponsor | Collaborator |
---|---|
Ralph Beltran |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Time it takes to insert an IV | between 1 to 30 minutes | ||
Secondary | Anticipated difficulty | Provider's prediction of how difficult it will be to start the IV on a Likert scale of 1-10, with 10 being the most difficult. | Baseline | |
Secondary | Actual difficulty | Provider's assessment of how difficult the actual IV insertion was on the same Likert scale. | between 1 to 30 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03181542 -
Infra Red Vein Visualization: Efficacy vs. Standard Technique
|
N/A | |
Completed |
NCT00740727 -
EASI Access II --- Follow-up Study to the EASI Access Trial
|
Phase 1 |